On the afternoon of August 26, 2026, Xu Runlong, President of Zhejiang Provincial Association of Chinese Medicine, and his entourage visited Benifit Pharmaceutical for research and guidance. Wu Hui, Member of the Standing Committee of Liandu District Party Committee and Deputy District Chief; Lan Yuechai, Director of the Drug Production Supervision Division of Lishui Municipal Administration for Market Regulation; Ye Qiaoyong, Vice‑President of Lishui Hospital of Traditional Chinese Medicine; Zeng Qunying, Director of Liandu District Administration for Market Regulation and other leading officials accompanied the investigation. Wu Lihua, Chairman of Benifit Pharmaceutical, and Zhang Liyun, Executive President, gave a warm reception.

Chairman Wu Lihua extended a warm welcome to the research group. He accompanied President Xu Runlong and his entourage on a tour of Benifit Pharmaceutical Exhibition Hall for Traditional Chinese Medicine Culture and Technology, and elaborated on the company’s achievements in inheriting traditional Chinese medicine culture, building a full‑industry‑chain layout and pursuing industrial innovation and development. As a practitioner of the modernization of traditional Chinese medicine, Benifit Pharmaceutical closely follows national strategies for TCM development and upholds its corporate mission of “Extracting the essence of Chinese herbal medicine, promoting the quintessence of national culture”. Leveraging local resources of “Nine Lishui Medicinal Herbs”, the company focuses on the core track of Chinese medicine formula granules and builds a full‑ecological TCM industrial chain integrating Chinese medicinal herb cultivation, scientific research, production, sales, medical treatment and health preservation. While refining and strengthening its core traditional Chinese medicine business, the company continues to make in‑roads into the general‑health sector. It actively advances the construction of the Smart Future Factory for General Health, explores edible‑fungus‑based health food, medical‑aesthetic cosmetics and functional health products, and builds a new general‑health industrial platform that combines intelligent manufacturing, scientific popularization and industrial tourism.

President Xu Runlong fully affirmed Benifit Pharmaceutical’s practical achievements in developing the full TCM industrial chain and exploring new tracks in general health. He pointed out that Lishui boasts unique ecological resources. Enterprises should capitalize on local strengths and translate premium ecological and authentic medicinal‑herb resources into advantages for high‑quality industrial development. It is essential to further tap the resource value and cultural connotation of indigenous authentic medicinal herbs, establish an integrated industry‑university‑research chain, and promote in‑depth integration and coordinated progress of TCM cultural inheritance, technological innovation and full‑industry‑chain development.

Going forward, Benifit Pharmaceutical will fully implement the guiding spirit of this field research. It will strengthen scientific and technological innovation, consolidate quality foundations, advance the inheritance and dissemination of TCM culture, and promote coordinated growth between its core traditional Chinese medicine business and its second growth curve in general‑health industry. With solid deliverables, the company will contribute to the industrialization and high‑quality modernization of traditional Chinese medicine and help bring the quintessential national culture of TCM to a broader international stage.